Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Olema Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −6 vs. Q4 2021
- Shares held
- 36.4M
- −2.05M (−5.3%) vs. Q4 2021
- Total value
- $155.2M
- −$204.3M (−56.8%) vs. Q4 2021
- New holders
- 15
- 24 more added
- Sold out
- 21
- 34 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −18,451−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,040−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −12,648−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,173−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −10,295−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −9,573−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −7,243−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −3,106−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −680−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −689−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −15−100.0% | Sold out |